[HTML][HTML] Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated?
IG Schoots, AR Padhani - World journal of urology, 2020 - Springer
Risk-based patient selection for systematic biopsy in prostate cancer diagnosis has been
adopted in daily clinical practice, either by clinical judgment and PSA testing, or using …
adopted in daily clinical practice, either by clinical judgment and PSA testing, or using …
Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated?
I Schoots, A Padhani - World Journal of Urology, 2019 - repub.eur.nl
Risk-based patient selection for systematic biopsy in prostate cancer diagnosis has been
adopted in daily clinical practice, either by clinical judgment and PSA testing, or using …
adopted in daily clinical practice, either by clinical judgment and PSA testing, or using …
[PDF][PDF] Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated?
IG Schoots, AR Padhani - 2019 - core.ac.uk
Risk-based patient selection for systematic biopsy in prostate cancer diagnosis has been
adopted in daily clinical practice, either by clinical judgment and PSA testing, or using …
adopted in daily clinical practice, either by clinical judgment and PSA testing, or using …
Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated?
IG Schoots, AR Padhani - World journal of urology, 2020 - pubmed.ncbi.nlm.nih.gov
Risk-based patient selection for systematic biopsy in prostate cancer diagnosis has been
adopted in daily clinical practice, either by clinical judgment and PSA testing, or using …
adopted in daily clinical practice, either by clinical judgment and PSA testing, or using …
[PDF][PDF] Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated?
IG Schoots, AR Padhani - World Journal of Urology, 2020 - scienceopen.com
Risk-based patient selection for systematic biopsy in prostate cancer diagnosis has been
adopted in daily clinical practice, either by clinical judgment and PSA testing, or using …
adopted in daily clinical practice, either by clinical judgment and PSA testing, or using …
Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated?
IG Schoots, AR Padhani - World Journal of Urology, 2019 - europepmc.org
Risk-based patient selection for systematic biopsy in prostate cancer diagnosis has been
adopted in daily clinical practice, either by clinical judgment and PSA testing, or using …
adopted in daily clinical practice, either by clinical judgment and PSA testing, or using …
Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated?
IG Schoots, AR Padhani - World Journal of Urology, 2020 - search.proquest.com
Risk-based patient selection for systematic biopsy in prostate cancer diagnosis has been
adopted in daily clinical practice, either by clinical judgment and PSA testing, or using …
adopted in daily clinical practice, either by clinical judgment and PSA testing, or using …
Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated?
IG Schoots, AR Padhani - World Journal of Urology, 2020 - search.ebscohost.com
Risk-based patient selection for systematic biopsy in prostate cancer diagnosis has been
adopted in daily clinical practice, either by clinical judgment and PSA testing, or using …
adopted in daily clinical practice, either by clinical judgment and PSA testing, or using …
[PDF][PDF] Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated?
IG Schoots, AR Padhani - 2019 - pure.eur.nl
Risk-based patient selection for systematic biopsy in prostate cancer diagnosis has been
adopted in daily clinical practice, either by clinical judgment and PSA testing, or using …
adopted in daily clinical practice, either by clinical judgment and PSA testing, or using …
[HTML][HTML] Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated?
IG Schoots, AR Padhani - World Journal of Urology, 2020 - ncbi.nlm.nih.gov
Risk-based patient selection for systematic biopsy in prostate cancer diagnosis has been
adopted in daily clinical practice, either by clinical judgment and PSA testing, or using …
adopted in daily clinical practice, either by clinical judgment and PSA testing, or using …